|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/7088 | |||
| A61K 31/70 | |||
| A61K 31/4745 | |||
| A61K 31/573 | |||
| A61K 31/475 | |||
| A61K 31/337 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61K 31/575 | |||
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Number of the document | 1971371 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06838847.9 |
| Date of filing the European patent application | 2006-12-01 | |
| (97) | Date of publication of the European application | 2008-09-24 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/046111 |
| Date | 2006-12-01 |
| (87) | Number | WO 2007/064945 |
| Date | 2007-06-07 |
| (30) | Number | Date | Country code |
| 741229 P | 2005-12-01 | US | |
| 778304 P | 2006-03-02 | US |
| (72) |
GOODWIN, Neal, Clifford, US
MC GOVREN, James Patrick, US
|
| (73) |
Pronai Therapeutics, Inc.,
4717 Campus Drive Suite 1100, Kalamazoo MI 49008,
US
|
| (54) | CANCER THERAPIES AND PHARMACEUTICAL COMPOSITIONS USED THEREIN |
| CANCER THERAPIES AND PHARMACEUTICAL COMPOSITIONS USED THEREIN |